±èÀçÇå ¸íÀÇ

¼÷·Á´ÜÇà ½Å»çµ¶Çà(ÃæºÐÈ÷ ½ÅÁßÈ÷ »ý°¢Çϰí Á¶½É½º·´°Ô ÇൿÇÑ´Ù)

±èÀçÇå ¸íÀÇ

  • ¼Ò ¼Ó
    ¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø ºñ´¢±â°ú
  • Àü¹®ºÐ¾ß
    ÃÖ¼Òħ½À¼ö¼ú (º¹°­°æ ¼ö¼ú ¹× ·Îº¿ ¼ö¼ú)/Àü¸³¼±Áúȯ/³²¼º

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¼øÃµÇâ´ë ÀÇ´ë Çлç
  • °í·Á´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¼øÃµÇâ´ëÇб³ ¼­¿ïº´¿ø ºñ´¢±â°ú ±³¼ö
  • ¹Ì±¹ ½ºÅÄÆ÷µå ´ëÇб³ ºñ´¢±â ¾Ï¼¾ÅÍ ±³È¯±³¼ö (2016 ~ 2017)

¼ö»ó³»¿ª

Awards List
  • ¼øÃµÇâ´ë ÃÖ¿ì¼ö Çмú¿¬±¸ÀÚ»ó ¼ö»ó (2024)
  • ±è¼¼Ã¶ ÇмúÀλó ¼ö»ó (2024)
  • Çѱ¹À» ºû³½ »ç¶÷µé (ÇѺû»ç)¿¡ ¿¬±¸³í¹® µîÀç (2023)
  • Çâ¼³¿¬±¸´ë»ó ¼ö»ó (2023)
  • ´ëÇÑÀü¸³¼±ÇÐȸ ÃÖ¿ì¼ö ÇØ¿Ü ³í¹®Çмú»ó ¼ö»ó (2023)
  • Àü¸³¼±ÇÐȸ BLUE Çмú»ó ¼ö»ó (2021)
  • ´ëÇÑÀü¸³¼±ÇÐȸ ¿ì¼öÇмú»ó (2021)
  • ¼øÃµÇâ´ëÇб³ Çмú¿¬±¸ ¿ì¼ö»ó (2019)
  • ¼øÃµÇâ´ëÇб³ ¼­¿ïº´¿ø ¿ÃÇØÀÇ ³í¹®»ó (2017)
  • ¼øÃµÇâ´ëÇб³ Àǰú´ëÇÐ µ¿¹®È¸ ¿ÃÇØÀÇ Çмú»ó (2016)
  • ¼øÃµÇâ´ëÇб³ Çмú¿¬±¸ ÃÖ¿ì¼ö»ó (2016)
  • ´ëÇѳ»ºñ´¢±â°úÇÐȸ ÇØ¿Ü¿ì¼ö³í¹® Çмú»ó (2015)
  • ´ëÇÑÀü¸³¼±ÇÐȸ ¿ì¼öÇмú»ó (2015)
  • ¼øÃµÇâ´ëÇб³ ¼­¿ïº´¿ø ¿ÃÇØÀÇ ³í¹®»ó (2015)
  • Marquis Who¡¯s Who in the World Àθí»çÀü µîÀç (2014 ~ 2018)
  • 2000 Outstanding Intellectuals of the 21st Century Àθí»çÀü µîÀç (2014~ 2017)
  • Çѹ̼öÇʹ®Çлó ¿ì¼ö»ó (2008)
  • Çѹ̼öÇʹ®Çлó Àå·Á»ó (2007)

ÇÐȸȰµ¿

Academic activities
  • 2025 ~ ´ëÇѺñ´¢ÀÇÇÐȸ Ãѹ«ÀÌ»ç
  • 2021 ~ ´ëÇÑÀü¸³¼±ÇÐȸ ¿¬±¸ÀÌ»ç
  • 2021 ~ ´ëÇѳ²¼º°»³â±âÇÐȸ ¿¬±¸ÀÌ»ç
  • 2021 ~ ´ëÇѳ²¼º°úÇÐȸ ¹ýÁ¦À±¸®ÀÌ»ç
  • 2019 ~ Çѱ¹À» ºû³½ »ç¶÷µé (ÇѺû»ç)¡¯¿¡ ¿¬±¸³í¹® µîÀç
  • 2018 ~ ´ëÇÑÀü¸³¼±ÇÐȸ Áø·áÁöħÀÌ»ç
  • 2018 ~ ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿¬±¸ÀÌ»ç
  • 2018 ~ Editorial board of ¡°World Journal of Men¡¯s Health¡±
  • 2018 ~ ´ëÇѺñ´¢±â°úÇÐȸ ÇмúÀ§¿øÈ¸ À§¿ø
  • 2017 ~ ´ëÇѳ²¼º°úÇÐȸ ±¹Á¦±³·ùÀÌ»ç
Bladder caner-Elsevier/Academic Press
´ëÇ¥¼­Àû

Bladder caner-Elsevier/Academic Press

  • ÀúÀÚ(±Û)
  • ÃâÆÇ»ç
  • ¹ßÇàÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 4°Ç
Á¦ ¸ñ Management of advanced prostate cancer-Springer
ÃâÆÇ»ç ¹ßÇàÀÏ
Á¦ ¸ñ Àü¸³¼±ºñ´ëÁõ Áø·á±Ç°í¾È-´ëÇѺñ´¢±â°úÇÐȸ
ÃâÆÇ»ç ¿¡ÀÌÇ÷¯½º±âȹ ¹ßÇàÀÏ
Á¦ ¸ñ ¿Ã¹Ù¸¥ °£ÇæÀûµµ´¢¹ý »ç¿ëÀ» À§ÇÑ ¾È³» Áöħ¼­-´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ
ÃâÆÇ»ç ¹ßÇàÀÏ
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Association between prostate-specific antigen and serum testosterone: A systematic review and meta-analysis. Kim DK, Noh JW, Chang Y, Lee HY, Park JJ, Ryu S, Kim JH. Andrology. 2020 Sep;8(5):1194-1213.
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Association between lower urinary tract symptoms and cigarette smoking or alcohol drinking. Noh JW, Yoo KB, Kim KB, Kim JH, Kwon YD. Transl Androl Urol. 2020 Apr;9(2):312-321.
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Association between sodium intake and lower urinary tract symptoms: does less sodium intake have a favorable effect or not? Noh JW, Kim KB, Kwon YD, Kim JH. Transl Androl Urol. 2020 Jun;9(3):1135-1145.
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Bilateral ureteral replacement using ileum in bilateral refractory ureteral stricture with renal insufficiency: a case report and review of literature. Park JJ, Yun S, Kim JH. Transl Androl Urol. 2020 Jun;9(3):1466-1474.
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ National Trends in the Treatment of Ruptured Cerebral Aneurysms in Korea Using an Age-adjusted Method. Park HR, Kim JH, Park S, Chang JC, Park SQ. J Korean Med Sci. 2020 Oct 12;35(39):e323.
¹ßÇ¥³âµµ 2021 ¹ßÇ¥Áö
Á¦ ¸ñ National Trends in the Treatment of Ruptured Cerebral Aneurysms in Korea Using an Age-adjusted Method. Park HR, Kim JH, Park S, Chang JC, Park SQ. J Korean Med Sci. 2020 Oct 12;35(39):e323.
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Persistence and Adherence of Anticholinergics and Beta-3 Agonist for the Treatment of Overactive Bladder: Systematic Review and Meta-Analysis, and Network Meta-Analysis. Song YS, Lee HY, Park JJ, Kim JH. J Urol. 2021 Jun;205(6):1595-1604.
¹ßÇ¥³âµµ 2021 ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø

Á¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-709-9114

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¼øÃµÇâ´ëÇб³¼­¿ïº´¿øÀº 1974³â ÇÏ´ÃÀÇ ¶æÀ» ¹Þµé¾î ÀμúÀ» ÆîÃİ¡´Â °íÇ⸶À»À» ¸¸µé¾î °¡°Ú´Ù´Â Àΰ£»ç¶û, »ý¸íÁ¸ÁßÀÇ ¼øÃµÇâ(â÷ô¸úÁ) Á¤½ÅÀ¸·Î °³¿øÇß´Ù. 32°³ Áø·á°ú¿Í 700 º´»óÀ» ¿î¿µÇϸç 220¿©¸íÀÇ ±³¼ö¿Í 2õ¿©¸íÀÇ ±³Á÷¿øÀÌ Áø·á¿Í ¿¬±¸, ±³À°¿¡ ÃÖ¼±À» ´ÙÇϰí ÀÖ´Ù. Áö¿ª½É³úÇ÷°ü¼¾ÅÍ ÁöÁ¤, ÁßȯÀÚ½Ç È®Àå, ¾Ï½Å¼ÓÁö¿ø¼¾ÅÍ, CAR-TÄ¡·á µîÀ¸·Î ÁßÁõ Áø·á¸¦ °­È­Çϰí, ÀÇ·áÁúÆò°¡ 1µî±Þ, ÀÀ±ÞÀÇ·á±â°ü Æò°¡ Aµî±Þ, ȯÀÚ°æÇèÆò°¡ Àü±¹13À§¸¦ ºñ·ÔÇØ °¢Á¾ ÀûÁ¤¼ºÆò°¡ 1µî±ÞÀ» À¯ÁöÇÏ¸ç ¾ÈÀüÇÑ Áø·á·Î »çȸÀû Ã¥ÀÓ°ú °¡Ä¡¸¦ ±¸ÇöÇϰí ÀÖ´Ù.

¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¿ë»ê±¸ ´ë»ç°ü·Î 59

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä